Fundraising Fox
/Companies
Sign in

Macromoltek

YC W18

Austin, US · Founded 2010 · 14 employees · 3 known investors

Find your way into Macromoltek

Sign up to see every warm intro you have to Macromoltek

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Macromoltek team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Macromoltek provides computational modeling and AI-driven antibody design services to biotech and pharmaceutical companies, accelerating the discovery and optimization of therapeutic antibodies. The platform reduces time-to-market and increases the probability of clinical success in drug development.

AI & Machine LearningBiotechHealthtechAI-powered Drug DiscoveryDeep LearningTherapeuticsUnited States of AmericaAmerica / Canada

Founders & leadership· Y Combinator alumni (W18)

Macromoltek was founded in 2010 by Monica Berrondo and Susana Kaufmann.

MBMonica Berrondo
Monica BerrondoCo-founder · CEOMonica Berrondo holds a Ph.D. and brings combined expertise in computational biology, antibody structure prediction, and protein analysis to Macromoltek.
SKSusana Kaufmann
Susana KaufmannCo-founder · CTOShe has over 25 years of software development experience across petrochemical, combustive engineering, pharmaceutical, and financial industries, with expertise in cross-platform development and computer simulation.
LH
Lisa HendricksonChief of Staffformer

Investors · 3

DCVC (Data Collective)reportedPalo Alto · $5M – $25M

How we know: funding news · Y Combinator's founder network · Not right? Tell us

Neotribe VenturesreportedMenlo Park · $250K – $2M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 10

Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
KeylikaKeylika develops a platform synthesis technology for mixed ligand metal complexes to generate organometallic drugs for treating therapeutic conditions including hematology, pain, inflammation, metabolic disorders, infectious diseases, and oncology. The company combines drug development with drug delivery technologies, customizing molecular structure and formulation to optimize clinical outcomes for women, children, elderly, and patients with specific diseases.
MatrubialsMatrubials develops antimicrobial peptides derived from milk to create novel therapeutics for bacterial infections, starting with bacterial vaginosis. The company uses AI-enabled technology to identify and validate bioactive molecules for infectious disease treatments.
NanograbNanograb develops gene therapy delivery systems using artificial intelligence to identify peptide-nanoparticle combinations that transport genetic medicines to targeted cells and tissues.
Aro BiotherapeuticsAro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins. The company builds a wholly-owned pipeline of Centyrin-based therapeutic candidates and partners with industry to enable tissue-specific targeting of therapeutics across a range of diseases.
Evolvere BioSciencesEvolvere BioSciences develops antibiotics using computational models and evolutionary data to target pathogenic bacteria while preserving beneficial microbes, designed to resist the development of bacterial resistance.
EmoleculeseMolecules operates a digital chemical search platform and procurement service connecting researchers to over 83 million available chemical compounds from a global supplier network. The company serves drug discovery researchers and biopharmaceutical organizations seeking to reduce timelines and improve efficiencies in early-stage compound acquisition and management.
Diffuse BioDiffuse designs proteins using AI models trained on experimental data collected through proprietary assays and software, delivering validated AI-designed proteins to partners.
ManifoldManifold Bio combines AI-guided protein design with high-throughput in vivo screening to engineer tissue-targeted biologics and deliver therapeutic payloads to specific organs. The company develops a computational and experimental platform to optimize pharmacokinetics and biodistribution directly in living systems for drug discovery and development.
MtemMolecular Templates, Inc. was a clinical-stage biopharmaceutical company formerly based in Austin, TX. The company is no longer operating.

Companies working in the same space as Macromoltek.

Non-dilutive funding · 2 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase II2016$750K
National Science FoundationPhase I2015$150K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Legal entities · 1

corporate structure
Macromoltek, Inc.

Frequently asked questions

What does Macromoltek do?
Macromoltek provides computational modeling and AI-driven antibody design services to biotech and pharmaceutical companies, accelerating the discovery and optimization of therapeutic antibodies. The platform reduces time-to-market and increases the probability of clinical success in drug development.
Who founded Macromoltek?
Macromoltek was founded by Monica Berrondo, Susana Kaufmann in 2010.
Who are Macromoltek's investors?
Macromoltek's investors include Y Combinator, DCVC (Data Collective), Neotribe Ventures.
Where is Macromoltek headquartered?
Macromoltek is headquartered in Austin, US.